<DOC>
	<DOCNO>NCT02856087</DOCNO>
	<brief_summary>High-dose remifentanil infuse intraoperative ironically result postoperative hyperalgesia . Ultra-low dose nalxone demonstrate prevent opioid-induced hyperalgesia animal model . In clinical trial patient undergo general anesthesia remifentanil , evaluate effect ultra-low-dose naloxone remifentanil-induced hyperalgesia</brief_summary>
	<brief_title>The Effect Ultra-low-dose Naloxone Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study</brief_title>
	<detailed_description>We enrol adult patient undergo thyroidectomy general anesthesia desflurane remifentanil . Remifentanil administer via target-controlled infusion anesthetic depth maintain keep BIS 40 60 . Patients randomize one three group depend intraoperative dos remifentanil naloxone : effect-site concentration remifentanil 1 ng/ml ( control group ) , 4 ng/ml ( remifentanil group ) , 4 ng/ml combine infusion rate 0.8 ng/kg/min naloxone ( remifentanil naloxone group ) . Postoperative mechanical pain threshold , pain intensity , analgesic consumption examine 48 h postoperative period . The primary outcome mechanical pain threshold measure peri-incisional area 24 h surgery .</detailed_description>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>patient schedule undergo elective thyroidectomy consent refusal , obesity , pregnancy , hx . thyroid surgery , neurological disorder , psychiatric disorder , hx . drug abuse chronic use opioids sedative drug , intake analgesic drug within 12h surgery .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>acute pain</keyword>
	<keyword>postoperative</keyword>
	<keyword>surgery</keyword>
</DOC>